Home Lilly profit beats analyst estimates as Cymbalta sales climb
 

Keywords :   


Lilly profit beats analyst estimates as Cymbalta sales climb

2013-01-29 16:01:20| Biotech - Topix.net

Eli Lilly and Co.'s fourth quarter earnings slipped 4 percent as generic competition continued to eat away at sales of its former best-seller, the antipsychotic Zyprexa, but the drugmaker cut expenses again and growth from other products helped it beat analyst expectations.

Tags: sales profit estimates analyst

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
01.11US jobs growth slows as presidential election looms
01.11Heritage Environmental Services Secures Commercial Permit Status for Orange, TX Incinerator
01.11Value for Money tsar linked to string of overspends
01.11Gimme Seaweed Partners with rePurpose Global to Combat Plastic Pollution
More »